Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
Premera Blue Cross February 2018 Medical Policy Updates
Click here to view the Premera Blue Cross Medical Policy Updates »
February 2018 Medical Policy Updates
Added 2/14/2018:
- 11.01.523 Site of Service: Infusion Drugs and Biologic Agents
- 5.01.536 Nulojix® (belatacept) for Adults
- 5.01.550 Pharmacotherapy of Arthropathies
- 5.01.556 Rituxan® (rituximab): Non-oncologic and Miscellaneous Uses
- 5.01.563 Pharmacotherapy of Inflammatory Bowel Disorder
- 5.01.564 Pharmacotherapy of Miscellaneous Autoimmune Diseases
- 5.01.570 (effective June 1, 2018) Exondys 51® (eteplirsen)
- 5.01.571 Soliris® (eculizumab)
- 8.01.503 Immune Globulin Therapy
2/07/2018:
- 01.19 Injectable Clostridial Collagenase for Fibroproliferative Disorders
- 01.30 Artificial Pancreas Device Systems
- 01.519 Patient Lifts, Seat Lifts and Standing Devices
- 01.520 Hospital Beds and Accessories
- 01.526 Durable Medical Equipment Repair/Replacement (Excluding Wheelchairs and C-Pap/BiPap Machines)
- 01.527 Power Operated Vehicles (Scooters) (excluding motorized wheelchairs)
- 01.528 Hearing Aids (Excludes Implantable Devices)
- 01.529 Durable Medical Equipment
- 01.504 Technology Review
- 01.511 Medical Policy and Clinical Guidelines: Definitions and Procedures
- 01.512 Ambulance and Medical Transport Services
- 01.517 Noncovered Services and Procedures
- 01.521 Routine Vision Care
- 01.522 Routine Foot Care Services
- 01.523 Preventive Care
- 01.510 Skilled Nursing Facility (SNF): Admission and Transition of Care Guideline
- 04.111 Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
- 04.510 Molecular Markers in Fine Needle Aspirates of the Thyroid
- 04.520 General Approach to Evaluating the Utility of Genetic Panels
- 01.21 Temporomandibular Joint Dysfunction
- 01.500 Allergy Testing
- 01.91 Peroral Endoscopic Myotomy (POEM) for Treatment of Esophageal Achalasia
- 04.125 Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer
- 04.509 Cardiovascular Risk Panels
- 04.62 Proteomics-Based Testing Related to Ovarian Cancer
- 04.84 Measurement of Serum Antibodies to Infliximab and Adalimumab
- 01.514 Trastuzumab and Other HER2 Inhibitors
- 01.534 Multiple Receptor Tyrosine Kinase Inhibitors
- 01.540 Miscellaneous Oral Oncology Drugs
- 01.547 Medical Necessity Criteria and Dispensing Quantity Limits for Exchange Formulary Benefits
- 01.555 Pharmacologic Treatment of Idiopathic Pulmonary Fibrosis
- 01.559 Mepolizumab (Nucala)
- 01.570 Exondys 51® (eteplirsen)
- 01.570 (effective June 1, 2018) Exondys 51® (eteplirsen)
- 01.581 Hemlibra® (emicizumab-kxwh)
- 01.582 Antibody-Drug Conjugates
- 01.603 Epidermal Growth Factor Receptor (EGFR) Inhibitors
- 01.546 Spinal Cord Stimulation
- 01.69 Sacral Nerve Neuromodulation/Stimulation
- 01.530 Hematopoietic Stem-Cell Transplantation for Primary Amyloidosis
- 03.502 Physical Medicine and Rehabilitation – Physical Therapy and Medical Massage Therapy
Click here to view the Premera Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
